Global Home Healthcare Market (2021 to 2028) - COVID-19 Impact and Analysis
September 09, 2021 07:03 ET
|
Research and Markets
Dublin, Sept. 09, 2021 (GLOBE NEWSWIRE) -- The "Home Healthcare Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product Type; Indication; Service; and Geography" report has been...
Global Solar Photovoltaic (PV) Market, Update 2021 - Market Size, Market Share, Major Trends, and Key Country Analysis to 2030
September 09, 2021 07:03 ET
|
ReportLinker
New York, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Solar Photovoltaic (PV) Market, Update 2021 - Market Size, Market Share, Major Trends, and...
Nabriva and Vizient Enter into Agreement to Make XENLETA® (lefamulin) Available to Vizient’s Pharmacy Network Program
September 09, 2021 07:01 ET
|
Nabriva Therapeutics US, Inc
DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of...
Tuesday Morning Corporation Announces Fiscal 2021 Results; Enhances Management Team With New Hires Across Key Areas of Organization
September 09, 2021 07:00 ET
|
Tuesday Morning Corp.
DALLAS, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Tuesday Morning Corporation (NASDAQ: TUEM), a leading off-price retailer of home goods and décor, today announced its results for the fourth quarter and...
SOPHiA GENETICS Reports Second Quarter 2021 Financial Results and Issues 2021 Guidance
September 09, 2021 07:00 ET
|
SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (NASDAQ: SOPH), today reported financial results for the three months ended June 30, 2021. Recent...
Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation from Founding Investor Versant Ventures
September 09, 2021 07:00 ET
|
Lycia Therapeutics, Inc.
-- Advancing novel targeted therapeutics using its LYTAC protein degradation technology -- -- Plans to use $105 million in recent capital, including $35 million upfront payment from strategic...
Anavex Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 09, 2021 07:00 ET
|
Anavex Life Sciences Corp.
NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
Aberdeen Investee, AES-100 Inc., Reports Technical Viability of Hydrogen Extraction From Natural Gas Pipelines Using the Advanced Electrolyzer System Technology
September 09, 2021 07:00 ET
|
Aberdeen International Inc.
TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Aberdeen International Inc. (“Aberdeen” or the “Company”) (TSX: AAB) (F: A8H) (OTC: AABVF) is pleased to announce that the team at AES-100 Inc....
Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2021
September 09, 2021 07:00 ET
|
ZENTALIS PHARMACEUTICALS
NEW YORK and SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small...
BioCryst Announces Approval of ORLADEYO® (berotralstat) in United Arab Emirates
September 09, 2021 07:00 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Ministry of Health and Prevention (MOHAP) in the United Arab...
- September 27, 2024 05:15 ET Online Trading Platforms Market Analysis and Investment Opportunities, 2030 - Rise of Zero-Commission Trading Models Attracting New Users
- September 27, 2024 05:01 ET Canada Alternative Lending Business Report 2024: Market to Grow by 26% to reach $2.17 Billion this Year - Product Launches and Innovations, Regulatory Changes, Mergers and Acquisitions to 2029